Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

Last updated: July 29, 2024
Sponsor: Mayo Clinic
Overall Status: Terminated

Phase

N/A

Condition

Sarcoma

Infantile Fibrosarcoma

Lung Cancer

Treatment

N/A

Clinical Study ID

NCT02613312
15-007645
NCI-2024-02057
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subject provides informed consent

  • Subject is >18 years of age

  • Subject is deemed competent for making medical decisions

  • Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT

  • Subject is a surgical candidate

  • A negative pregnancy test is required in women of child-bearing potential, asstandard of care.

Exclusion

Exclusion Criteria:

•Subject is <18 years old.

Study Design

Total Participants: 8
Study Start date:
March 18, 2016
Estimated Completion Date:
October 05, 2020

Study Description

The investigators will consent patients that have been diagnosed with mesothelioma and will undergo chemotherapy followed by surgery and then IMRT as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.

Connect with a study center

  • Mayo Clinic in Rochester

    Rochester, Minnesota 55905
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.